tirzepatide what does it do to your body Injections Near Me in Dayton and Yellow Springs, OH Tirzepatide for Diabetes and Weight

In the SURPASS-2 trial for type 2 diabetes, gastrointestinal adverse events showed a dose-dependent relationship, with higher doses (10 mg and 15 mg) associated with increased frequency of digestive symptoms compared to lower doses (5 mg)

Among those who did not discontinue semaglutide and were on a high maintenance dose, mean weight loss was 14.7% at 1 year

With adequate nutrition and treatment, regrowth is likely within 3 to 6 months

Together, these changes result in fewer smooth muscle contractions and a slower flow of food through the stomach and intestinal tract

Achieving and sustaining clinically meaningful weight reduction remains a key goal in obesity treatment